Table 1.
Comparison of baseline clinical characteristics and the results of various tests among various groups.
| Clinical characteristic | TBP (n = 73) | Non-TBP (n = 135) | ||
|---|---|---|---|---|
| ODC (n = 83) | CON (n = 52) | Total (n = 135) | ||
| Age (years) | 39.05 ± 19.44 | 54.20 ± 17.80∗ | 49.96 ± 10.51∗ | 52.57 ± 15.49& |
| Male (%) | 34 (46.58) | 52 (62.65)∗ | 15 (28.85)∗# | 67 (49.62) |
| Median of ESR mm/H (IQR) | 36.00 (21.50, 55.00) | 30.00 (18.00, 49.00) | 7.00 (3.25, 12.00)∗# | 19.00 (7.00, 34.00)& |
| Median of serum ADA U/L (IQR) | 20.47 (14.04, 28.81) | 12.91 (8.84, 25.30)∗ | 9.50 (7.26, 10.39)∗# | 10.36 (8.56, 15.70)& |
| Median of hs-CRP mg/L (IQR) | 87.48 (27.25, 106.90) | 19.61 (4.49, 43.28)∗ | 1.03 (0.32, 4.95)∗# | 6.33 (1.04, 25.11)& |
| Positive TB-Ab (%) | 5 (6.85) | 0 (0.00)∗ | 1 (1.92)∗# | 1 (0.74)& |
| Positive T-SPOT.TB (%) | 69 (94.52) | 32 (38.55)∗ | 8 (15.38)∗# | 40 (29.63)& |
| Median of QFT IU/mL (IQR) | 1.9 (0.76, 3.43) | 0.05 (-0.01, 0.64)∗ | 0.02 (-0.01, 0.16)∗ | 0.02 (-0.01, 0.24)& |
| Median of serum CA125 U/mL (IQR) | 223.40 (57.40, 449.72) | 135.89 (18.61, 399.34) | 8.59 (6.09, 12.05)∗# | 18.81 (8.61, 183.03)& |
| Ascites extract (%) | 40 (54.79) | 31 (37.35) | 0 (0.00) | — |
| Median of ascitic CA125 U/mL (IQR) | 691.30 (398.72, 1212.58) | 1071.00 (564.89, 1879.34)∗ | — | — |
| Median of ascitic ADA U/L (IQR) | 55.89 (48.68, 69.96) | 5.81 (2.25, 10.07)∗ | — | — |
Note: ∗Compared with group TBP, p < 0.05, #compared with group ODC, p < 0.05, &compared with group TBP, p < 0.05. n: number of patients; TBP: tuberculous peritonitis; ODC: other-disease control; CON: control; ESR: erythrocyte sedimentation rate; ADA: adenosine deaminase; hs-CRP: high-sensitivity C-reactive protein; TB-Ab: tuberculosis antibody; T-SPOT.TB: tuberculosis-infected T-cells spot test; QFT: Quanti FERON-TB; CA125: cancer antigen 125.